PUT - SPRINTER OPEN END - NOVO-NORDISK B | Market Closed - Boerse Frankfurt Warrants 14:00:55 2024-07-04 EDT | ||
| 2.87 EUR | -3.69% |
|
| Current month | +20.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
| Date | Price | Change |
|---|---|---|
| 24-07-04 | 2.87 | -3.69% |
| 24-07-03 | 2.98 | +18.25% |
| 24-07-02 | 2.52 | +10.04% |
| 24-07-01 | 2.29 | -3.78% |
| 24-06-28 | 2.38 | +0.85% |
Real-time Boerse Frankfurt Warrants
Last update July 04, 2024 at 02:00 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Vontobel
|
| WKN | VD7EZG |
| ISIN | DE000VD7EZG0 |
| Date issued | 2024-06-05 |
| Strike | 1,181 kr |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.45 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.05 € |
|---|---|
| Lowest since issue | 2.06 € |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
970
DKK
Average target price
952.2
DKK
Spread / Average Target
-1.84%
- Stock Market
- Certificates
- Certificat
